Course Catalog
Browse our full catalog of continuing education courses and events
Browse Courses & Events
Medical Crossfire®: Translating Risk into Action—Redefining Adjuvant Strategies for Early HR+/HER2– Breast Cancer
Ann H. Partridge, MD, MPH; William J. Gradishar, MD, FASCO, FACP; Saranya Chumsri, MD
Coffee Talk: Charting New Pathways with HER2 and TROP2 Therapies – From Early to Advanced Breast Cancer
Hope S. Rugo, MD, FASCO; Paolo Tarantino, MD, PhD; Alastair Thompson, MD, MBChB, BSc (Hons), FRCS (E...
Live Tumor Board: Squamous Cell Carcinoma of the Head & Neck - Post-CRT Decisions in the Locally Advanced Setting
Quynh-Thu Le, MD, FACR, FASTRO; Vlad C. Sandulache, MD, PhD
Cutting-Edge Care in Neovascular Retinal Disease: Expert Approaches to Selection and Interval Extension
Geeta Lalwani, MD; Alla Goldberg, MD; Elite Bor-Shavit, MD
Next-Generation Solutions for nAMD and DME: Bridging Evidence and Practice Gaps in Disease Management
Murtaza K. Adam, MD, FASRS; Deepak Sambhara, MD, FASRS; Betty Zhang, OD
Facilitating Precision Pathways: Surgical Considerations in Breast Cancer for Tackling Barriers to Genetic Testing and Targeted Therapies
Patrick I. Borgen, MD; Don S. Dizon, MD, FACP, FASCO; Kevin S. Hughes, MD, FACS; Banu Arun, MD, FASC...
Show Me the Data™: Translating Clinical and Practice-Based Evidence on Oral SERDs Into Everyday Care for HR+/HER2– Metastatic Breast Cancer
Reshma L. Mahtani, DO; Kamel Abou Hussein, MD; Irene Kang, MD
Obesity: New and Emerging Strategies to Optimally Manage a Chronic Disease
June 5, 2026
Show Me the Data®: How Today’s Evidence Is Shaping Tomorrow’s Management and Prophylaxis of Chronic GVHD
Carrie L. Kitko, MD; Miguel-Angel Perales, MD; Amandeep Salhotra, MD
Medical Crossfire®: Breakthroughs in Non–Muscle-Invasive Bladder Cancer: Advancing Patient Care Through Innovation in Treatment
Ashish M. Kamat, MD, MBBS; Katie S. Murray, DO, MS; Thomas Powles, MD, MBBS, MRCP
Emerging Therapeutic Advancements in Dry Eye Disease Management
Rahul Tonk, MD; Jade Coats, OD, FAAO; Aaleya Koreishi, MD; Zeba Syed, MD
Medical Crossfire®: Optimizing 𝘌𝘚𝘙1 Mutation Detection and Next-Generation Endocrine Therapy Integration in HR+/HER2– Breast Cancer
VK Gadi, MD, PhD; Neil M. Iyengar, MD; Heather McArthur, MD, MPH
New Precision Strategies for HER2+ GEA: Interpreting New Data to Inform Clinical Practice
Rahul Gosain, MD, MBA; Rohit Gosain, MD; Sunnie Kim, MD; Samuel L. Cytryn, MD
Medical Crossfire®: Redefining Frontline and Maintenance Strategies in HER2+ Metastatic Breast Cancer
Joyce O’Shaughnessy, MD; Reshma L. Mahtani, DO; Heather McArthur, MD, MPH; Paolo Tarantino, MD, PhD
Medical Crossfire®: Advancing Personalized Care in TNBC—Integrating Biomarkers, Clinical Evidence, and Emerging Therapies
Adam Brufsky, MD, PhD; Kamel Abou Hussein, MD; Priyanka Sharma, MD, FASCO
Medical Crossfire®: Expanding Options, Evolving Challenges in Advanced HR+/HER2– Breast Cancer: How Experts Apply the Latest Data
Kevin Kalinsky, MD, MS; Adam Brufsky, MD, PhD; Kelly Elizabeth McCann, MD, PhD; Sara Nunnery, MD, MS...
Medical Crossfire®: Menin Inhibitors in AML—Dissecting the Data to Define the Role
Naval Daver, MD; Courtney DiNardo, MD; Eunice Wang, MD
Current and Future Directions in Precision-Based ALL Therapy
Elias Jabbour, MD; Hagop M. Kantarjian, MD; Aaron C. Logan, MD, PhD, MPhil
From Molecular Insights to Clinical Impact: Translating the Latest Advances in Menin Inhibitors Into Practice
Naval G. Daver, MD; Amir Fathi, MD; Guillermo Garcia-Manero, MD; Aditi Shastri, MD
Embracing the Interventional Glaucoma Mindset: A Paradigm Shift in Contemporary Glaucoma Management
Mary Qiu, MD; Paul Singh, MD; Danica J. Marrelli, OD, FAAO
Live Tumor Board: From Trial to Practice–Integrating the Latest Evidence Into the Treatment of EGFR-Mutated NSCLC
Jonathan Riess, MD, MS; Fawzi Abu Rous, MD; Julia Rotow, MD
Medical Crossfire®: PD-L1 Inhibition in Advanced Cutaneous Squamous Cell Carcinoma — Mechanistic Rationale and Clinical Application
April K.S. Salama, MD; Omid Hamid, MD; James M. G. Larkin, MD, PhD; Sapna Patel, MD
Live Tumor Board: Precision Pathways Transforming Patient Care in Advanced NSCLC
Narjust Florez, MD, FASCO; David P. Carbone, MD, PhD; Edward B. Garon, MD, MS
Shifting the Paradigm in Small Cell Lung Cancer: Targeting Tumor Biology to Transform Patient Outcomes
Charles M. Rudin, MD, PhD; Alex A. Adjei, MD, PhD; Millie Das, MD
Practical Strategies for Monitoring and Managing Toxicities With Novel Therapies for HER2-Positive Gastroesophageal Adenocarcinoma
June 15, 2026
Tumor Board: Translating HER2 and TROP2 Innovations to Transform NSCLC Care
Jacob Sands, MD; Marina Chiara Garassino, MD; Eric K. Singhi, MD
Decoding HER2 Alterations in GEA: Best Practices for Testing and Treatment
Rahul Gosain, MD, MBA; Rohit Gosain, MD; Rondell P. Graham, MBBS; Tanios S. Bekaii-Saab, MD
Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia
Gus Alva, MD, DFAPA; Erin Crown, MHS, PA-C
Combination Approaches in PD-L1–Positive mTNBC: Practice-Changing Frontline Evidence
Rahul Gosain, MD, MBA; Rohit Gosain, MD; Sherene Loi, MMBS (Hons), FRACP, PhD, FAHMS
First-Line ADC Monotherapy in mTNBC: Addressing Unmet Needs in Immunotherapy-Ineligible Populations
Rahul Gosain, MD, MBA; Rohit Gosain, MD; Adam Brufsky, MD, PhD
Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?
Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD
Show Me the Data™—Closing Clinical Gaps in Gastric and Esophageal Cancer: Advancing Targeted Treatment Strategies Across the Care Continuum
Manish A. Shah, MD, FASCO; Syma Iqbal, MD; Haeseong Park, MD, MPH
Cases and Conversations: Navigating the New Immunotherapy Era in Squamous Cell Anal Carcinoma
Marwan Fakih, MD; Kristen Ciombor, MD, MSCI; Van Karlyle Morris, MD
Collaborating Across the Continuum®: A Team-Based Approach to Earlier Detection and Smarter Treatment in LN
Shivani Garg, MD, PhD; Samir V. Parikh, MD, FASN; Kimberly DeQuattro, MD, MM
Show Me the Data™: Incorporating the Latest Advances in Immunotherapy and EGFR-Targeted Treatments for Resectable, Early-Stage NSCLC
Mara Antonoff, MD, FACS; Laura Alder, MD; Stephanie Worrell, MD, FACS
“D” is for Diagnosis: Decoding a Difficult Thoracic Malignancy—Piecing Together a Rare Diagnosis, Preparing for Tomorrow’s Treatments
Aakash Desai, MD, MPH; Ibiayi Dagogo-Jack, MD, FASCO; Patrick Forde, MD, PhD
Medical Crossfire®: Navigating Chronic GVHD Prophylaxis and Treatment – Targeted Strategies to Elevate Patient Outcomes
Corey Cutler, MD, MPH, FRCP(C); Amin M. Alousi, MD; Mehdi Hamadani, MD; Anna Sureda, MD, PhD
The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights
Damon Dierker, OD FAAO; Maria Pribis, OD
Tumor Board™: Navigating a New Era of Innovation and Expanding Options in NMIBC
Archan Khandekar, MD; Wassim Kassouf, MD, CM, FRCSC; Jen-Jane Liu, MD
Medical Crossfire®: Advancements in Chronic Myeloid Leukemia: Treatment Strategies, Mechanisms, and Patient Management
Jorge E. Cortes, MD; Hagop Kantarjian, MD; Neil P. Shah, MD, PhD; Kendra Sweet, MD
Medical Crossfire®: Advances in ALL Management Across the Patient Spectrum: Integrating Innovation and Precision Care
Elias Jabbour, MD; Hagop Kantarjian, MD; Aaron Logan, MD, PhD, MPhil; Rob Pieters, MD, PhD; Claire R...
Medical Crossfire®: Experts Debate the Hottest Topics in AML – FLT3, IDH1/2, KMT2Ar, NPM1, Secondary AML, Maintenance, Novel Combinations, and Emerging Therapies
Naval Daver, MD; Daniel A. Pollyea, MD; Gail J. Roboz, MD; Amer Zeidan, MBBS, MHS
Cases and Conversations™: Optimizing Patient Outcomes in Pediatric/AYA and Adult ALL/LBL With Asparaginase Therapies and Combinations
Daniel J. DeAngelo, MD, PhD; Shira Dinner, MD; Stephen P. Hunger, MD; Jae H. Park, MD
Cases and Conversations: Real-World Insights on Advances in the Management of Myeloproliferative Neoplasms: How the Experts Apply the Latest Developments to Clinical Practice
Naveen Pemmaraju, MD; Shannon Elf, PhD; Angela Fleischman, MD, PhD; Bethan Psaila, MD
PER® Tumor Board: Charting a New Course in the Treatment of Newly Diagnosed Multiple Myeloma
Ajai Chari, MD; Maria-Victoria Mateos, MD, PhD; Mohamad Mohty, MD, PhD
From Suspicion to Stabilization: Early Recognition and Treatment of Paraneoplastic LEMS
Charu Aggarwal, MD, MPH, FASCO; Erminia Massarelli, MD, PhD, MS; Ruham Nasany, MD
Burst CME™: Transition from Pediatric to Adult Care in Sickle Cell Disease
Biree Andemariam, MD; Nirmish Shah, MD
Burst CME™: Optimal Management of Complications of Sickle Cell Disease
Matthew Heeney, MD; Deepika S, Darbari, MD